These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6987254)

  • 1. Dwarfism associated with normal serum growth hormone and increased bioassayable, receptorassayable, and immunoassayable somatomedin.
    Lanes R; Plotnick LP; Spencer EM; Daughaday WH; Kowarski AA
    J Clin Endocrinol Metab; 1980 Mar; 50(3):485-8. PubMed ID: 6987254
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute and long term responses to hGH in children with idiopathic small-for-dates dwarfism.
    Grunt JA; Enriquez AR; Daughaday WH
    J Clin Endocrinol Metab; 1972 Jul; 35(1):157-68. PubMed ID: 5032510
    [No Abstract]   [Full Text] [Related]  

  • 3. Pituitary dwarfism in a patient with circulating abnormal growth hormone polymers.
    Valenta LJ; Sigel MB; Lesniak MA; Elias AN; Lewis UJ; Friesen HG; Kershnar AK
    N Engl J Med; 1985 Jan; 312(4):214-7. PubMed ID: 3965948
    [No Abstract]   [Full Text] [Related]  

  • 4. Short stature associated with normal growth hormone and decreased somatomedin-C concentrations: response to exogenous growth hormone.
    Bright GM; Rogol AD; Johanson AJ; Blizzard RM
    Pediatrics; 1983 Apr; 71(4):576-80. PubMed ID: 6340044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrepancies between bioassayable somatomedin activity and somatomedin C levels in acromegalic patients.
    Jasper HG; Artese R; Molocznik I; Bruno O
    Medicina (B Aires); 1986; 46(4):440-4. PubMed ID: 3574106
    [No Abstract]   [Full Text] [Related]  

  • 6. [Short stature and growth hormone].
    Okada Y; Hikita T; Ishitobi K; Harada Y
    Horumon To Rinsho; 1972 Apr; 20(4):285-90. PubMed ID: 4559326
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth failure with normal serum RIA-GH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH.
    Kowarski AA; Schneider J; Ben-Galim E; Weldon VV; Daughaday WH
    J Clin Endocrinol Metab; 1978 Aug; 47(2):461-4. PubMed ID: 263308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioreceptor assay of insulin-like peptides in human plasma: growth hormone dependence and correlation with sulfation activity by two bioassays.
    Guyda HJ; Corvol MT; Rappaport R; Posner BI
    J Clin Endocrinol Metab; 1979 May; 48(5):739-47. PubMed ID: 429519
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in a somatomedin-like factor and immunoassayable growth hormone during growth of normal and dwarf pullets and cockerels.
    Hoshino S; Wakita M; Suzuki M; Yamamoto K
    Poult Sci; 1982 Apr; 61(4):777-84. PubMed ID: 7100063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioassayable growth hormone activity in blood from healthy individuals and acromegalic patients.
    Thorngren KG; Hallengren B
    Acta Endocrinol (Copenh); 1986 Jan; 111(1):3-9. PubMed ID: 3946103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor in pregnancy: studies in a growth hormone-deficient dwarf.
    Merimee TJ; Zapf J; Froesch ER
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1101-3. PubMed ID: 7042729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of somatomedin A and growth during long-term treatment of patients with pituitary dwarfism with human growth hormone.
    Takano K; Hizuka N; Shizume K; Hasumi Y
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):385-97. PubMed ID: 229685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels.
    Tamborlane WV; Hintz RL; Bergman M; Genel M; Felig P; Sherwin RS
    N Engl J Med; 1981 Aug; 305(6):303-7. PubMed ID: 7017416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate.
    Rosenfeld RG; Kemp SF; Hintz RL
    J Clin Endocrinol Metab; 1981 Sep; 53(3):611-7. PubMed ID: 7021582
    [No Abstract]   [Full Text] [Related]  

  • 15. A child with phenotypic Laron dwarfism and normal somatomedin levels.
    Pintor C; Loche S; Cella SG; Müller EE; Baumann G
    N Engl J Med; 1989 Feb; 320(6):376-9. PubMed ID: 2913494
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucose tolerance, growth hormone and somatomedin levels in osteosarcoma patients.
    Adamson U; Broström LA; Efendić S; Hall K
    Acta Endocrinol (Copenh); 1980 Aug; 94(4):517-22. PubMed ID: 7001830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay.
    Furlanetto RW; Underwood LE; Van Wyk JJ; D'Ercole AJ
    J Clin Invest; 1977 Sep; 60(3):648-57. PubMed ID: 893668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoassayable serum somatomedin B in normal subjects and in patients with acromegaly and pituitary dwarfism: effects of human growth hormone therapy.
    Wajchenberg BL; Liberman B; Gomes EN; Pieroni RR
    Horm Metab Res; 1980 Oct; 12(10):516-9. PubMed ID: 7439876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dwarfism with elevated levels of plasma growth hormone.
    Najjar SS; Khachadurian AK; Ilbawi MN; Blizzard RM
    N Engl J Med; 1971 Apr; 284(15):809-12. PubMed ID: 5549802
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasma growth hormone and blood sugar levels during insulin and arginine loading in dwarfism in children].
    Ito R
    Nihon Shonika Gakkai Zasshi; 1970 May; 74(5):519-32. PubMed ID: 5464709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.